title: Endocrine Therapy with Selective Estrogen Receptor Modulators (SERMs) and Aromatase Inhibitors in the Prevention and Adjuvant Therapy Settings.
authors: Division of Hematology/Oncology, Department of Medicine, Loyola University Chicago Stritch School of Medicine, Cardinal Bernardin Cancer Center, Maywood, IL, USA, shlo@lumc.edu.
authors: Shelly S
authors: SS
authors: Lo
authors: Kathleen I
authors: KI
authors: Pritchard
authors: Patricia
authors: P
authors: Robinson
authors: Kathy S
authors: KS
authors: Albain
mesh_terms: D047072:Aromatase Inhibitors; D001943:Breast Neoplasms / Q000517:prevention & control; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D006801:Humans; D020845:Selective Estrogen Receptor Modulators
chemical_list: D047072:Aromatase Inhibitors; D020845:Selective Estrogen Receptor Modulators